140 related articles for article (PubMed ID: 2470994)
1. Vascular effects of carvedilol, a new beta-adrenoceptor antagonist with vasodilating properties, in isolated canine coronary artery.
Hattori Y; Nakaya H; Endou M; Nakao Y; Kanno M
J Cardiovasc Pharmacol; 1989 Apr; 13(4):572-9. PubMed ID: 2470994
[TBL] [Abstract][Full Text] [Related]
2. In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol.
Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
Pharmacology; 1989; 39(5):327-36. PubMed ID: 2575762
[TBL] [Abstract][Full Text] [Related]
3. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of bucindolol in isolated canine vascular smooth muscle.
Rimele TJ; Aarhus LL; Lorenz RR; Rooke TW; Vanhoutte PM
J Pharmacol Exp Ther; 1984 Nov; 231(2):317-25. PubMed ID: 6149305
[TBL] [Abstract][Full Text] [Related]
5. Alpha and beta adrenoceptor blocking action of carvedilol in the canine mesenteric artery and vein.
Seki N; Nagao T; Komori K; Suzuki H
J Pharmacol Exp Ther; 1988 Sep; 246(3):1116-22. PubMed ID: 2901485
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure.
Qvigstad E; Sjaastad I; Bøkenes J; Schiander I; Solberg L; Sejersted OM; Osnes JB; Skomedal T
Eur J Pharmacol; 2005 May; 516(1):51-9. PubMed ID: 15916756
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of carvedilol on calcium channels in vascular smooth muscle cells.
Nakajima T; Ma J; Iida H; Iwasawa K; Jo T; Omata M; Nagai R
Jpn Heart J; 2003 Nov; 44(6):963-78. PubMed ID: 14711191
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
Nichols AJ; Gellai M; Ruffolo RR
Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
[TBL] [Abstract][Full Text] [Related]
9. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
Hirohashi M; Takasuna K; Tamura K; Yamaguchi K; Maekawa K; Yamada S; Iwasaki S; Yoshida M; Nomura M; Taguchi K
Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
[TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the possible involvement of Ca2+ entry blockade in the relaxation by class I antiarrhythmic drugs in the isolated pig coronary smooth muscle.
Tanaka Y; Kamibayashi M; Yamashita Y; Imai T; Tanaka H; Nakahara T; Ishii K; Shigenobu K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):56-66. PubMed ID: 11862334
[TBL] [Abstract][Full Text] [Related]
12. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia.
Hashimoto H; Kanda A; Hubo H; Tanaka M
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S22-8. PubMed ID: 1721975
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of the beta-adrenoceptor blocker carvedilol on calcium regulation during oxidative stress-induced apoptosis in cardiomyocytes.
Wang R; Miura T; Harada N; Kametani R; Shibuya M; Fukagawa Y; Kawamura S; Ikeda Y; Hara M; Matsuzaki M
J Pharmacol Exp Ther; 2006 Jul; 318(1):45-52. PubMed ID: 16611853
[TBL] [Abstract][Full Text] [Related]
14. K+ channel-opening action and KRN2391-induced reduction of Ca2+ sensitivity of arterial smooth muscle.
Okada Y; Yanagisawa T; Yamagishi T; Taira N
Arch Int Pharmacodyn Ther; 1993; 326():33-51. PubMed ID: 8185411
[TBL] [Abstract][Full Text] [Related]
15. Methanol-induced contraction of canine cerebral artery and its possible mechanism of action.
Li W; Altura BT; Altura BM
Toxicol Appl Pharmacol; 1998 Jun; 150(2):361-8. PubMed ID: 9653067
[TBL] [Abstract][Full Text] [Related]
16. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
Yue TL; Cheng HY; Lysko PG; McKenna PJ; Feuerstein R; Gu JL; Lysko KA; Davis LL; Feuerstein G
J Pharmacol Exp Ther; 1992 Oct; 263(1):92-8. PubMed ID: 1357162
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol, a new vasodilating beta-adrenoceptor blocker, inhibits oxidation of low-density lipoproteins by vascular smooth muscle cells and prevents leukocyte adhesion to smooth muscle cells.
Yue TL; Wang X; Gu JL; Ruffolo RR; Feuerstein GZ
J Pharmacol Exp Ther; 1995 Jun; 273(3):1442-9. PubMed ID: 7791119
[TBL] [Abstract][Full Text] [Related]
18. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
Chirality; 1989; 1(4):265-70. PubMed ID: 2577144
[TBL] [Abstract][Full Text] [Related]
19. Effects of adrenomedullin and calcitonin gene-related peptide on contractions of the rat aorta and porcine coronary artery.
Yoshimoto R; Mitsui-Saito M; Ozaki H; Karaki H
Br J Pharmacol; 1998 Apr; 123(8):1645-54. PubMed ID: 9605572
[TBL] [Abstract][Full Text] [Related]
20. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
